Eagle Pharmaceuticals, Inc. Total Liabilities
Eagle Pharmaceuticals, Inc. had Total Liabilities of $152.78 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-08-09
- 2023-06-30: Liabilities $152.78M.
- 2023-03-31: Liabilities $171.33M.
- 2022-12-31: Liabilities $172.60M.
- 2022-09-30: Liabilities $154.67M.
| Period end | Liabilities |
|---|---|
| 2023-06-30 | $152.78M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $171.33M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $172.60M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $154.67M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $143.77M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $104.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $77.28M 10-K · filed 2023-03-23 |
| 2021-09-30 | $70.97M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $69.39M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $68.89M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $67.18M 10-K · filed 2022-03-08 |
| 2020-09-30 | $75.37M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $72.75M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $180.11M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $75.38M 10-K · filed 2021-03-05 |
| 2018-12-31 | $77.84M 10-K · filed 2020-03-02 |